TheraCryf PLC (TCF)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.16p

Buy

0.18p

arrow-up0.00p (+0.00%)

Prices updated at 13 Nov 2026, 12:39 GMT

Prices minimum 15 mins delay

Prices in GBX

TheraCryf PLC is a biotechnology company developing new medicines for addiction and other neuropsychiatric disorders, areas of unmet medical need within central nervous system (CNS) disorders. The Group's main programme is a novel, benchmark orexin-1 ...

FTSE All-Share

0.27%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

14 Sep 2026

11 Sep 2026

10 Sep 2026

07 Sep 2026

20 Aug 2026

26 May 2026

15 May 2026

14 May 2026

16 Apr 2026

Key dates

	Forecast date
Annual general meeting	Oct 2027
Final results	Sep 2027
Annual report	Sep 2027
Half yearly results	Dec 2026

	Previous date
Annual general meeting	Oct 2026
Final results	Sep 2026
Annual report	Sep 2026
Half yearly results	Dec 2025

Company reports

31 Mar 2026

Annual Report

30 Sep 2025

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.